Form 4: Teradyne CEO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Teradyne's President and CEO, Gregory Stephen Smith, sold 1,108 shares of common stock for $145.24 per share as part of a pre-arranged 10b5-1 trading plan.
Summary
- Gregory Stephen Smith, President and CEO and Director of Teradyne, Inc. (TER), reported a sale of common stock.
- The transaction involved the disposition of 1,108 shares of Teradyne common stock.
- The shares were sold at a price of $145.24 per share, totaling $160,945.12.
- Following this transaction, Gregory Stephen Smith beneficially owns 94,776.995 shares of common stock.
- The sale was executed on October 10, 2025, and was conducted under a Rule 10b5-1 sales plan adopted on February 4, 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale can sometimes be perceived negatively, the fact that it was conducted under a Rule 10b5-1 plan mitigates concerns, as it indicates a pre-scheduled transaction for personal financial management rather than a reaction to new, negative company information.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 plan, indicating a planned disposition rather than a reaction to recent company performance or new material information.
Negatives
- An insider sale, even under a 10b5-1 plan, reduces the direct equity alignment of a key executive with shareholder interests, albeit in a pre-scheduled manner.
Risks
- Potential for market misinterpretation of insider sales, even when pre-planned, which could lead to short-term negative sentiment if the context of the 10b5-1 plan is overlooked.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This insider transaction is a routine disclosure for a publicly traded company and does not inherently reflect broader industry trends or competitive positioning. Such sales are common for executives managing personal finances and diversifying portfolios.
Stakeholder Impact
- Shareholders may observe a slight reduction in the CEO's direct equity stake, though the 10b5-1 plan context suggests this is for personal financial planning rather than a lack of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 2025-02-04 | Date the Rule 10b5-1 sales plan was adopted by the Reporting Person. |
| 2025-10-10 | Date of the reported transaction (sale of common stock). |
| 2025-10-15 | Date the Form 4 was signed by the Attorney-in-Fact. |
Recommendation
holdThe insider sale by Teradyne's CEO, while a disposition of shares, was conducted under a pre-arranged Rule 10b5-1 plan. This type of plan is designed to allow insiders to sell shares without being accused of trading on material non-public information, as the plan is set up in advance. Therefore, this specific transaction is generally considered a routine personal financial management event rather than a signal of negative company prospects. It does not provide new information that would warrant a change in investment thesis, hence a 'hold' recommendation is appropriate.
Keywords
Teradyne, TER, Insider Trading, Form 4, Gregory Stephen Smith, CEO, Stock Sale, 10b5-1 Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.